Head-to-head · WeighScore
CoreAge Rx vs Walgreens Weight Management
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 62.8/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Walgreens Weight Management |
|---|---|---|
| WeighScore | 89.5/100 | 62.8/100 |
| Grade | B+ | C |
| Site position | #1 | #300 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | Medication extra; $49 per visit; branded oral/injectable options with conditional savings |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | Medication extra; $49 per visit; dose-specific Zepbound savings and refill conditions |
| Coverage | US only; therapy-specific state restrictions apply | 48 states; excludes AL and LA; Medicare Bridge footprint differs |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #300 · C
Strengths
- No subscription required; initial and follow-up visits are $49 each
- Branded injectable and oral treatment options
- Current weight-management page offers prior-authorization help for eligible commercially insured patients
What to consider
- Medication and any required testing cost extra; insurance does not pay the visit fee
- Generic help pages still conflict with the new prior-authorization offer
- Standard service excludes AL and LA; Medicare Bridge has more exclusions
- No refund solely because a clinician declines the requested prescription
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.